Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. (CELU) on May 16, 2025, covering events occurring on May 14, 2025. The Company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On May 14, 2025, Dean Kehler resigned as a member of the Board of Directors. The Company explicitly stated that his resignation was not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Key Facts for Investors
- Dean Kehler has resigned from the Board of Directors effective May 14, 2025.
- The resignation was voluntary and not due to any disagreement with the Company.
- Robert J. Hariri, M.D., Ph.D., signed the report in his capacity as Chairman and CEO.
- No financial results or operational updates were included in this specific filing.